Literature DB >> 6018241

Enhancement of dinitrochlorobenzene (DNCB) contact sensitization by cyclophosphamide in the guinea pig.

H C Maguire, V L Ettore.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6018241     DOI: 10.1038/jid.1967.6

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  21 in total

Review 1.  Exploitation of the propulsive force of chemotherapy for improving the response to cancer immunotherapy.

Authors:  Enrico Proietti; Federica Moschella; Imerio Capone; Filippo Belardelli
Journal:  Mol Oncol       Date:  2011-12-03       Impact factor: 6.603

2.  Delayed-type hypersensitivity elicited by synthetic peptides complexed with Mycobacterium tuberculosis hsp 70.

Authors:  E Roman; C Moreno
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

3.  Cancer chemotherapeutics as immunomodulators.

Authors:  F Spreafico; A Vecchi; F Colotta; A Montovani
Journal:  Springer Semin Immunopathol       Date:  1985

4.  Effects of cyclophosphamide and a metabolite, acrolein, on Naegleria fowleri in vitro and in vivo.

Authors:  L Zhang; F Marciano-Cabral; S G Bradley
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

5.  Regional lymph node x-radiation suppresses allograft rejection.

Authors:  H C Maguire; B D Jaffee
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

6.  Cyclophosphamide intensifies the acquisition of allergic contact dermatitis in mice rendered B-cell deficient by heterologous anti-IgM antisera.

Authors:  H C Maguire; L Faris; W Weidanz
Journal:  Immunology       Date:  1979-06       Impact factor: 7.397

7.  Evaluation of lymphocyte immunity in breast cancer patients.

Authors:  J F Head; R L Elliott; J L McCoy
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

8.  Cyclophosphamide pretreatment and protection against malaria.

Authors:  J F Finerty; E P Krehl
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

9.  Phenotype, functions and fate of adoptively transferred tumor draining lymphocytes activated ex vivo in mice with an aggressive weakly immunogenic mammary carcinoma.

Authors:  Catriona H T Miller; Laura Graham; Harry D Bear
Journal:  BMC Immunol       Date:  2010-11-04       Impact factor: 3.615

10.  Enhanced expansion of the thymic CD8+ cell subset as a potential mechanism for the generation of enhanced antitumor cytotoxicity by thymocytes from low-dose melphalan-treated MOPC-315 tumor bearers.

Authors:  M M Bartik; B A Baumgartel-Scofield; M B Mokyr
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.